C. I. Bloom, C. Huggins, G. Díaz-Fuentes, N. Sabharwal
{"title":"Impact of a Certified Asthma Educator Pharmacist on Medication Adherence in Patients with Persistent Asthma in an Inner-City Hospital","authors":"C. I. Bloom, C. Huggins, G. Díaz-Fuentes, N. Sabharwal","doi":"10.18314/jpt.v4i1.1260","DOIUrl":null,"url":null,"abstract":"Background: The medication management for people with asthma (MMA) Healthcare Effectiveness Data and Information Set (HEDIS) measure assesses adherence to controller therapy >75% of the calendar year. A new “Action List” feature recently incorporated into Allscripts, the hospital electronic health record (EHR), is used by a certified asthma educator (AE-C) pharmacist to track both the progress of and to improve patients’ MMA measures.Objective: To evaluate the impact of an AE-C pharmacist using an EHR Action List on improving the number of patients with a MMA >75% compared to a pre-intervention group. Methods: This was a retrospective, pre-post cohort study assessing the impact of an AE-C pharmacist on 2017 versus 2016 calendar year MMA measures. During the intervention period, the AE-C pharmacist conducted patient follow-up calls, as per the Action List, for refill reminders and identification/resolution of nonadherence. Providers were contacted for prescription renewals and insurance formulary changes. This data was compared with historical data from 2016.Results: One-hundred and fifty-five patients were identified, 100 in the 2017 pharmacyintervention group and 55 in the pre-intervention (pre Action List) group. There was no significant increase in the MMA >75% measure in the Action List group when compared with the pre-intervention group (46% vs. 34.6%, p=0.1667). More patients who met the MMA measure were seen by a pulmonologist versus a primary care provider in both groups.Conclusions: The AE-C pharmacist intervention was associated with a non-significant 11.4% increase in patients with a MMA >75%. This small preliminary study suggests promising results for the use of pharmacists to improve HEDIS measures, especially in PCP clinics.","PeriodicalId":16742,"journal":{"name":"Journal of Pharmaceutics and Therapeutics","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutics and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18314/jpt.v4i1.1260","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The medication management for people with asthma (MMA) Healthcare Effectiveness Data and Information Set (HEDIS) measure assesses adherence to controller therapy >75% of the calendar year. A new “Action List” feature recently incorporated into Allscripts, the hospital electronic health record (EHR), is used by a certified asthma educator (AE-C) pharmacist to track both the progress of and to improve patients’ MMA measures.Objective: To evaluate the impact of an AE-C pharmacist using an EHR Action List on improving the number of patients with a MMA >75% compared to a pre-intervention group. Methods: This was a retrospective, pre-post cohort study assessing the impact of an AE-C pharmacist on 2017 versus 2016 calendar year MMA measures. During the intervention period, the AE-C pharmacist conducted patient follow-up calls, as per the Action List, for refill reminders and identification/resolution of nonadherence. Providers were contacted for prescription renewals and insurance formulary changes. This data was compared with historical data from 2016.Results: One-hundred and fifty-five patients were identified, 100 in the 2017 pharmacyintervention group and 55 in the pre-intervention (pre Action List) group. There was no significant increase in the MMA >75% measure in the Action List group when compared with the pre-intervention group (46% vs. 34.6%, p=0.1667). More patients who met the MMA measure were seen by a pulmonologist versus a primary care provider in both groups.Conclusions: The AE-C pharmacist intervention was associated with a non-significant 11.4% increase in patients with a MMA >75%. This small preliminary study suggests promising results for the use of pharmacists to improve HEDIS measures, especially in PCP clinics.